isospaglumic acid has been researched along with xanthenes in 9 studies
| Studies (isospaglumic acid) | Trials (isospaglumic acid) | Recent Studies (post-2010) (isospaglumic acid) | Studies (xanthenes) | Trials (xanthenes) | Recent Studies (post-2010) (xanthenes) |
|---|---|---|---|---|---|
| 469 | 31 | 116 | 5,020 | 92 | 1,325 |
| Protein | Taxonomy | isospaglumic acid (IC50) | xanthenes (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 7.42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Lin, S; Rhodes, PG | 1 |
| Ebinger, G; Hachimi-Idrissi, S; Michotte, Y; Sarre, S; Van Hemelrijck, A | 1 |
| Bzdega, T; Neale, JH; Olszewski, RT; Wegorzewska, IN; Wroblewska, B | 1 |
| Ashby, CR; Gardner, EL; Li, J; Peng, XQ; Slusher, BS; Thomas, A; Wozniak, K; Xi, ZX | 1 |
| Fujita, Y; Hashimoto, K; Slusher, BS; Takatsu, Y; Tsukamoto, T | 1 |
| Raiteri, L; Raiteri, M; Romei, C | 1 |
| Fu, K; Furukawa-Hibi, Y; Iegaki, N; Ishikawa, Y; Miyamoto, Y; Muramatsu, S; Nabeshima, T; Nitta, A; Sato, K; Sumi, K; Uno, K | 1 |
| Cannella, LA; Gregg, RA; Hicks, C; Nayak, SU; Rawls, SM; Reitz, AB; Schena, GJ; Smith, GR; Tallarida, CS | 1 |
| Chen, W; Lai, M; Liu, H; Mei, D; Zhang, F; Zhou, W; Zhu, H | 1 |
9 other study(ies) available for isospaglumic acid and xanthenes
| Article | Year |
|---|---|
Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
Topics: Amino Acids; Animals; Animals, Newborn; Brain; Carboxypeptidases; Cyclic AMP; Cycloleucine; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Hippocampus; Hypoxia-Ischemia, Brain; Neurons; Neuroprotective Agents; Organophosphorus Compounds; Propionates; Rats; Rats, Sprague-Dawley; Xanthenes | 2002 |
Neuroprotective effect of N-acetyl-aspartyl-glutamate in combination with mild hypothermia in the endothelin-1 rat model of focal cerebral ischaemia.
Topics: Amino Acids; Animals; Blood-Brain Barrier; Brain Ischemia; Dipeptides; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Endothelin-1; Hypothermia; Male; Microdialysis; Neuroprotective Agents; Rats; Rats, Wistar; Time Factors; Xanthenes | 2005 |
Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes.
Topics: Amino Acids; Animals; Animals, Newborn; Astrocytes; Cerebellum; Cyclic GMP; Dipeptides; Excitatory Amino Acid Antagonists; GTP-Binding Proteins; Neurons; Nitroprusside; Pertussis Toxin; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Xanthenes | 2006 |
Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats.
Topics: Administration, Oral; Amino Acids; Animals; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Dipeptides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutamate Carboxypeptidase II; Glutarates; Male; Rats; Receptors, Metabotropic Glutamate; Reward; Self Administration; Stereoisomerism; Sucrose; Sulfhydryl Compounds; Time Factors; Xanthenes | 2010 |
Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in mice.
Topics: Administration, Oral; Amino Acids; Animals; Antipsychotic Agents; Bridged Bicyclo Compounds; Dipeptides; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Glutarates; Male; Mice; Neural Inhibition; Schizophrenia; Sensory Gating; Sulfhydryl Compounds; Xanthenes | 2011 |
Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate (NAAG).
Topics: Amino Acids; Animals; Bridged Bicyclo Compounds, Heterocyclic; Dipeptides; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Exocytosis; Glutamic Acid; Glycine; Male; Mice; Potassium Chloride; Receptors, Metabotropic Glutamate; Spinal Cord; Synaptosomes; Xanthenes | 2013 |
Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice.
Topics: Acetyltransferases; Amino Acids; Animals; Aspartic Acid; Conditioning, Psychological; Corpus Striatum; Dipeptides; Dopamine; Male; Methamphetamine; Mice; Mice, Transgenic; Motor Activity; Nucleus Accumbens; Receptors, Metabotropic Glutamate; Xanthenes | 2014 |
Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
Topics: Alkaloids; Amino Acids; Animals; Benzodioxoles; Conditioning, Psychological; Dipeptides; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Male; Organophosphorus Compounds; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reward; Synthetic Cathinone; Xanthenes | 2017 |
N-acetylaspartylglutamate Inhibits Heroin Self-Administration and Heroin-Seeking Behaviors Induced by Cue or Priming in Rats.
Topics: Amino Acids; Analysis of Variance; Animals; Conditioning, Operant; Cues; Dipeptides; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Excitatory Amino Acid Antagonists; Heroin; Male; Motivation; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Self Administration; Time Factors; Xanthenes | 2017 |